期刊文献+

施氏假单胞菌的临床分布及其耐药性研究 被引量:2

Clinical Distribution and Drug Resistance of Pseudomonas stutzeri
原文传递
导出
摘要 目的:研究施氏假单胞菌的临床分布情况及其耐药性。方法:收集1994年6月至2010年11月福建医科大学附属泉州市第一医院门诊及病房分离出的23株施氏假单胞菌的资料,分析其临床分布情况,采用琼脂扩散法检测其耐药性。结果:23株施氏假单胞菌在各个年度、临床科室中均呈散在分布,标本分布以痰为主(15株,占65.2%);对庆大霉素、阿米卡星、多黏菌素B、头孢曲松、环丙沙星、头孢他啶、哌拉西林、亚胺培南的耐药率分别为56.5%、52.2%、0、39.1%、26.1%、8.7%、26.1%、4.3%。结论:施氏假单胞菌对氨基糖苷类较为耐药,对多黏菌素B、头孢曲松、环丙沙星、哌拉西林、头孢他啶、亚胺培南较为敏感。 OBJECTIVE: To study the clinical distribution and drug resistance of Pseudomonas stutzeri. MPSIHUDS: 23 strains of P stuzeri isolated from outpatient department and wards of quanzhou municipal first hospital affiliated to fujian medical universi- ty during Jun. 1994--Nov. 2010 were collected and analyzed in respect of clinical distribution. Bacteria resistance of P stuzeri was detected using agar diffusion method. RESULTS: 23 strains of P stuzeri distributed diffusely in clinical departments during Jun. 1994-Dec. 2010; isolated samples were mainly sputum (15 strains, 65.2% ); drug resistances to gentamicin, amikacin, polymyx- in B, cephalosporin aspergillus, ciprofloxacin, ceftazidime, piperacillin and imipenem were 56.5%, 52.2%, 0, 39.1%, 26.1%, 8.7 %, 26.1%, 4.3%, respectively. CONCLUSIONS: P. stuzeri is resistant to aminoglycoside, and sensitive to polymyxin B, ceph- alosporin aspergillus, ciprofloxacin, piperacillin, ceftazidime and imipenem.
出处 《中国药房》 CAS CSCD 2013年第14期1276-1277,共2页 China Pharmacy
关键词 施氏假单胞菌 临床分布 耐药性 Pseudomonas stutzeri Clinical distribution Drug resistance
  • 相关文献

参考文献8

  • 1Noble RC, Overman SB. Pseudomonas stutzeri infection.A review of hospital isolates and a review of the literature[J]. Diagn Microbiol Infect Dis,1994,19(1):51.
  • 2Lalucat J,Bennasar A,Bosch R,et al.Biology of Pseudo-monas stutzeri[J].Micraczol Mol Biol Rev, 2006, 70(2):510.
  • 3Sikorski J, Lalucat J, Wackemagel W.Genomovars 11 to18 of Pseudomonas stutzeri, identified among isolatesfrom soil and marine sediment[J]. Int J Syst Evol Microbiol,2005,55(Pt 5):1 767.
  • 4Scotta C, Mulet M, Sanchez D,et al. Identification andgenomovar assignation of clinical strains of Pseudomonasstutzeri[J]. Eur J Clin Microbiol Infect Dis,2012,31(9):2 133.
  • 5Poirel L, Rodriguez-Martinez JM, Al Naiemi N, et al.Characterization of DIM-1, an integron-encoded metal-lo-beta-lactamase from a Pseudomonas stutzeri clinicalisolate in the Netherlands[J]. Antimicrob Agents Chemoth-er,2010,54(6):2 420.
  • 6National Committee for Clinical Laboratory Standards. Per-formance standards for antimicrobial disk susceptibility^^s[S].NCCLS,1996: M100-S6.
  • 7National Committee for Clinical Laboratory Standards. Per-formance standards for antimicrobial disk susceptibilityf&^s[S]‘NCCLS,1999:M100-S9.
  • 8Nicolosi D, NicolosiVM,Cappellani A, et a/.Antibioticsusceptibility profiles of uncommon bacterial speciescausing severe infections in Italy [J]. J Chemother,2009,21(3):253.

同被引文献15

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部